glp 1 sleep apnea The pleiotropic effects of glucagon-like peptide-1 receptor agonists GLP-1 for Sleep Apnea |

Given the established clinical use of GLP-1RAs for the treatment of T2DM, preclinical and clinical research was centered largely around DR, which suggested the neuropathologic protective effects of GLP-1 are due to downregulation of NF-B, proinflammatory cytokines such as TNF-alpha and IL-1beta, and VEGF

Overall, 66% (41/62) of patents listed at the time of first paragraph IV certification on these four GLP-1 receptor agonists were device patents

doi:10.2147/CE.S55944

Flannery PJ, Trushina E

Koceva A, Herman R, Janez A, Rakusa M, Jensterle M

doi: 10.1016/j.molmet.2018.09.009 64 BerndtSIGustafssonSMgiRGannaAWheelerEFeitosaMFet al